{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:38:04Z","timestamp":1760549884954},"reference-count":33,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1248\/bpb.b15-00356","type":"journal-article","created":{"date-parts":[[2015,10,31]],"date-time":"2015-10-31T18:06:45Z","timestamp":1446314805000},"page":"1732-1737","source":"Crossref","is-referenced-by-count":11,"title":["Effects of 1\u03b1,25-Dihydroxyvitamin D&lt;sub&gt;3&lt;\/sub&gt; on Intestinal Absorption and Disposition of Adefovir Dipivoxil and Its Metabolite, Adefovir, in Rats"],"prefix":"10.1248","volume":"38","author":[{"given":"In-Soo","family":"Yoon","sequence":"first","affiliation":[{"name":"College of Pharmacy and Natural Medicine Research Institute, Mokpo National University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Hyeng","family":"Son","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Seoul National University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Bum","family":"Kim","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Seoul National University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Koo","family":"Choi","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Dankook University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Joo","family":"Maeng","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Gachon University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Thomas DR. Vitamins in aging, health, and longevity. <i>Clin. Interv. Aging<\/i>, <b>1<\/b>, 81\u201391 (2006).","DOI":"10.2147\/ciia.2006.1.1.81"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Mullin GE, Dobs A. Vitamin D and its role in cancer and immunity: a prescription for sunlight. <i>Nutr. Clin. Pract.<\/i>, <b>22<\/b>, 305\u2013322 (2007).","DOI":"10.1177\/0115426507022003305"},{"key":"3","unstructured":"3) Pilz S, Gaksch M, Hartaigh BO, Tomaschitz A, Marz W. Vitamin D in preventive medicine. <i>Anticancer Res.<\/i>, <b>35<\/b>, 1161\u20131170 (2015)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. <i>Trends Biochem. Sci.<\/i>, <b>29<\/b>, 664\u2013673 (2004).","DOI":"10.1016\/j.tibs.2004.10.005"},{"key":"5","unstructured":"5) Bouillon R, Suda T. Vitamin D: calcium and bone homeostasis during evolution. <i>Bonekey Rep.<\/i>, <b>3<\/b>, 480 (2014)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E. Transcriptional control of intestinal cytochrome P-4503\u2009A by 1alpha,25-dihydroxy vitamin D<sub>3<\/sub>. <i>Mol. Pharmacol.<\/i>, <b>60<\/b>, 1399\u20131406 (2001).","DOI":"10.1124\/mol.60.6.1399"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Chen X, Chen F, Liu S, Glaeser H, Dawson PA, Hofmann AF, Kim RB, Shneider BL, Pang KS. Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1alpha,25-dihydroxyvitamin D<sub>3<\/sub> <i>via<\/i> the vitamin D receptor. <i>Mol. Pharmacol.<\/i>, <b>69<\/b>, 1913\u20131923 (2006).","DOI":"10.1124\/mol.105.020792"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Fan J, Liu S, Du Y, Morrison J, Shipman R, Pang KS. Up-regulation of transporters and enzymes by the vitamin D receptor ligands, 1alpha,25-dihydroxyvitamin D<sub>3<\/sub> and vitamin D analogs, in the Caco-2 cell monolayer. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>330<\/b>, 389\u2013402 (2009).","DOI":"10.1124\/jpet.108.149815"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Chow EC, Durk MR, Cummins CL, Pang KS. 1alpha,25-Dihydroxyvitamin D<sub>3<\/sub> up-regulates P-glycoprotein <i>via<\/i> the vitamin D receptor and not farnesoid X receptor in both fxr(\u2212\/\u2212) and fxr(+\/+) mice and increased renal and brain efflux of digoxin in mice <i>in vivo.<\/i> <i>J. Pharmacol. Exp. Ther.<\/i>, <b>337<\/b>, 846\u2013859 (2011).","DOI":"10.1124\/jpet.111.179101"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Chow EC, Sun H, Khan AA, Groothuis GM, Pang KS. Effects of 1alpha,25-dihydroxyvitamin D<sub>3<\/sub> on transporters and enzymes of the rat intestine and kidney <i>in vivo.<\/i> <i>Biopharm. Drug Dispos.<\/i>, <b>31<\/b>, 91\u2013108 (2010).","DOI":"10.1002\/bdd.694"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sandgren ME, Bronnegard M, DeLuca HF. Tissue distribution of the 1,25-dihydroxyvitamin D<sub>3<\/sub> receptor in the male rat. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>181<\/b>, 611\u2013616 (1991).","DOI":"10.1016\/0006-291X(91)91234-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Tachibana S, Yoshinari K, Chikada T, Toriyabe T, Nagata K, Yamazoe Y. Involvement of vitamin D receptor in the intestinal induction of human ABCB1. <i>Drug Metab. Dispos.<\/i>, <b>37<\/b>, 1604\u20131610 (2009).","DOI":"10.1124\/dmd.109.027219"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Maeng HJ, Chapy H, Zaman S, Pang KS. Effects of 1alpha,25-dihydroxyvitamin D<sub>3<\/sub> on transport and metabolism of adefovir dipivoxil and its metabolites in Caco-2 cells. <i>Eur. J. Pharm. Sci.<\/i>, <b>46<\/b>, 149\u2013166 (2012).","DOI":"10.1016\/j.ejps.2012.02.018"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Chow EC, Maeng HJ, Liu S, Khan AA, Groothuis GM, Pang KS. 1alpha,25-Dihydroxyvitamin D<sub>3<\/sub> triggered vitamin D receptor and farnesoid X receptor-like effects in rat intestine and liver <i>in vivo<\/i>. <i>Biopharm. Drug Dispos.<\/i>, <b>30<\/b>, 457\u2013475 (2009).","DOI":"10.1002\/bdd.682"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Maeng HJ, Durk MR, Chow EC, Ghoneim R, Pang KS. 1alpha,25-Dihydroxyvitamin D<sub>3<\/sub> on intestinal transporter function: studies with the rat everted intestinal sac. <i>Biopharm. Drug Dispos.<\/i>, <b>32<\/b>, 112\u2013125 (2011).","DOI":"10.1002\/bdd.742"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) De Clercq E. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. <i>Clin. Microbiol. Rev.<\/i>, <b>16<\/b>, 569\u2013596 (2003).","DOI":"10.1128\/CMR.16.4.569-596.2003"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ming X, Thakker DR. Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil. <i>Biochem. Pharmacol.<\/i>, <b>79<\/b>, 455\u2013462 (2010).","DOI":"10.1016\/j.bcp.2009.08.029"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Imaoka T, Kusuhara H, Adachi M, Schuetz JD, Takeuchi K, Sugiyama Y. Functional involvement of multidrug resistance-associated protein 4 (MRP4\/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. <i>Mol. Pharmacol.<\/i>, <b>71<\/b>, 619\u2013627 (2007).","DOI":"10.1124\/mol.106.028233"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Buti M, Esteban R. Adefovir dipivoxil. <i>Drugs Today<\/i>, <b>39<\/b>, 127\u2013135 (2003).","DOI":"10.1358\/dot.2003.39.2.799419"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Annaert P, Van Gelder J, Naesens L, De Clercq E, Van den Mooter G, Kinget R, Augustijns P. Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers. <i>Pharm. Res.<\/i>, <b>15<\/b>, 1168\u20131173 (1998).","DOI":"10.1023\/A:1011923420719"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Annaert P, Kinget R, Naesens L, de Clercq E, Augustijns P. Transport, uptake, and metabolism of the bis(pivaloyloxymethyl)-ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine in an <i>in vitro<\/i> cell culture system of the intestinal mucosa (Caco-2). <i>Pharm. Res.<\/i>, <b>14<\/b>, 492\u2013496 (1997).","DOI":"10.1023\/A:1012155717819"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kim SB, Yoon IS, Kim KS, Cho SJ, Kim YS, Cho HJ, Chung SJ, Chong S, Kim DD. <i>In vitro<\/i> and <i>in vivo<\/i> evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism. <i>Planta Med.<\/i>, <b>80<\/b>, 561\u2013567 (2014).","DOI":"10.1055\/s-0034-1368350"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kim JE, Cho HJ, Kim JS, Shim CK, Chung SJ, Oak MH, Yoon IS, Kim DD. The limited intestinal absorption <i>via<\/i> paracellular pathway is responsible for the low oral bioavailability of doxorubicin. <i>Xenobiotica<\/i>, <b>43<\/b>, 579\u2013591 (2013).","DOI":"10.3109\/00498254.2012.751140"},{"key":"24","unstructured":"24) Cho HJ, Park JW, Yoon IS, Kim DD. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. <i>Int. J. Nanomedicine<\/i>, <b>9<\/b>, 495\u2013504 (2014)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Kim JE, Yoon IS, Cho HJ, Kim DH, Choi YH, Kim DD. Emulsion-based colloidal nanosystems for oral delivery of doxorubicin: improved intestinal paracellular absorption and alleviated cardiotoxicity. <i>Int. J. Pharm.<\/i>, <b>464<\/b>, 117\u2013126 (2014).","DOI":"10.1016\/j.ijpharm.2014.01.016"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Ahmed Z, Gopinath B, Shetty A, Sridhar B. Development and validation of RP-HPLC method for the determination of adefovir dipivoxil in bulk and in pharmaceutical formulation. <i>Journal of Chemistry<\/i>, <b>6<\/b>, 469\u2013474 (2009).","DOI":"10.1155\/2009\/157868"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Yoon IS, Choi MK, Kim JS, Shim CK, Chung SJ, Kim DD. Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol. <i>Xenobiotica<\/i>, <b>41<\/b>, 243\u2013251 (2011).","DOI":"10.3109\/00498254.2010.538090"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Han SY, Yoon I, Chin YW, Cho IW, Lee MG, Choi YH. Pharmacokinetic interaction between metoprolol and SP-8203 in rats: competitive inhibition for the metabolism of metoprolol by SP-8203 <i>via<\/i> hepatic CYP2D subfamily. <i>Xenobiotica<\/i>, <b>42<\/b>, 1017\u20131027 (2012).","DOI":"10.3109\/00498254.2012.663117"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Kim YC, Kim IB, Noh CK, Quach HP, Yoon IS, Chow EC, Kim M, Jin HE, Cho KH, Chung SJ, Pang KS, Maeng HJ. Effects of 1alpha,25-dihydroxyvitamin D<sub>3<\/sub>, the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat. <i>J. Pharm. Sci.<\/i>, <b>103<\/b>, 3793\u20133805 (2014).","DOI":"10.1002\/jps.24195"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Annaert P, Tukker JJ, van Gelder J, Naesens L, de Clercq E, van Den Mooter G, Kinget R, Augustijns P. <i>In vitro<\/i>, <i>ex vivo<\/i>, and <i>in situ<\/i> intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil. <i>J. Pharm. Sci.<\/i>, <b>89<\/b>, 1054\u20131062 (2000).","DOI":"10.1002\/1520-6017(200008)89:8<1054::AID-JPS10>3.0.CO;2-5"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Wang BF, Wang Y, Wang BY, Sun FR, Zhang D, Chen YS. Osteomalacia and Fanconi\u2019s syndrome caused by long-term low-dose adefovir dipivoxil. <i>J. Clin. Pharm. Ther.<\/i>, <b>40<\/b>, 345\u2013348 (2015).","DOI":"10.1111\/jcpt.12259"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Eguchi H, Tsuruta M, Tani J, Kuwahara R, Hiromatsu Y. Hypophosphatemic osteomalacia due to drug-induced Fanconi\u2019s syndrome associated with adefovir dipivoxil treatment for hepatitis B. <i>Intern. Med.<\/i>, <b>53<\/b>, 233\u2013237 (2014).","DOI":"10.2169\/internalmedicine.53.1213"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Kim du H, Sung DH, Min YK; Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review. <i>J. Bone Miner. Metab.<\/i>, <b>31<\/b>, 240\u2013246 (2013).","DOI":"10.1007\/s00774-012-0384-y"}],"container-title":["Biological &amp; Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/38\/11\/38_b15-00356\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T01:07:35Z","timestamp":1567300055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/38\/11\/38_b15-00356\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b15-00356","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}